GlaxoSmithKline Intellectual Property (No. 2) Limited;GLAXOSMITHKLINE IP NO 2 LTD
发明人:
申请号：
EP12765641.1
公开号：
EP2688568B1
申请日:
2012.03.26
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
This invention relates to the use of cyclopropylamine derivatives for the modulation, notably the inhibition of the activity of Lysine-specific demethylase 1 (LSD1). Suitably, the present invention relates to the use of cyclopropylamines in the treatment of cancer.
